Items where Author is "Woodroofe, M. N."

[up]

Group by: Item Type | Full Text | No Grouping

Jump to: Article

Number of items: 10.

Article

DENNEY, H., CLENCH, M. and WOODROOFE, M. N. (2009). Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis. Biochemical and biophysical research communications, 382 (2), 341-347. [Article]

HURST, L. A., BUNNING, R. A. D., COURAUD, P.-O., ROMERO, I. A., WEKSLER, B. B., SHARRACK, B. and WOODROOFE, M. N. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. Journal of neuroimmunology, 210 (1-2), 108-112. [Article]

REID, M. J., CROSS, A. K., HADDOCK, G., ALLAN, S. M., STOCK, C. J., WOODROOFE, M. N., BUTTLE, D. J. and BUNNING, R. A. D. (2009). ADAMTS-9 expression is up-regulated following transient middle cerebral artery occlusion (tMCAo) in the rat. Neuroscience letters, 452 (3), 252-257. [Article]

BRADFORD, C. M., CROSS, A. K., HADDOCK, G. and WOODROOFE, M. N. (2009). Citrullination in MS: potential for a new diagnostic test. British journal of neuroscience nursing, 5 (1), 1-13. [Article]

TAYLOR, D., DALTON, C., HALL, A., WOODROOFE, M. N. and GARDINER, P. H. E. (2009). Recent developments in selenium research. British journal of biomedical science, 66 (2), 107-116. [Article]

HADDOCK, G., CROSS, A. K., ALLAN, S., SHARRACK, B., CALLAGHAN, J. T., BUNNING, R. A., BUTTLE, D. J. and WOODROOFE, M. N. (2007). Brevican and phosphacan expression and localization following transient middle cerebral artery occlusion in the rat. Biochemical Society Transactions, 35 (4), p. 692. [Article]

HADDOCK, G., CROSS, A. K., PLUMB, J., SURR, J., BUTTLE, D. J., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Expression of ADAMTS-1, -4, -5 and TIMP-3 in normal and multiple sclerosis CNS white matter. Multiple Sclerosis, 12 (4), 386-396. [Article]

PLUMB, J., MCQUAID, S., CROSS, A. K., SURR, J., HADDOCK, G., BUNNING, R. A. D. and WOODROOFE, M. N. (2005). Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Multiple Sclerosis, 12 (4), 375-385. [Article]

KEMP, H. E., METCALFE, R. A., SMITH, K. A., WOODROOFE, M. N., WATSON, P. F. and WEETMAN, A. P. (2003). Detection and localization of chemokine gene expression in autoimmune thyroid disease. Clinical endocrinology, 59 (2), 207-213. [Article]

GODDARD, D. R., BUNNING, R. A. D. and WOODROOFE, M. N. (2001). Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia, 34 (4), p. 267. [Article]

This list was generated on Fri Sep 27 08:30:41 2024 UTC.